TP53 and cancer: It is possible that, due to the observed mutations in p53 in this type of cancer, a change occurred in this case resulting in a reduction in the interaction between SV40 and p53, which in turn led to a relative decrease in the number of SV40 antigen copies and a weaker immunohistochemical reaction [36].